“Why AIVAe Might Be the Next Billion-Dollar Innovation in Healthcare AI”
Earlier this week, Forbes profiled the remarkable rise of a healthcare AI assistant built for doctors. It embedded seamlessly into medical workflows, automating documents and saving clinicians time and in doing so, built a company now worth over $1 billion.
The headline was clear:
“This AI Founder Became a Billionaire by Building ChatGPT for Doctors.”
At PharmBot AI, we couldn’t help but reflect on the parallels.
Because while that system is empowering physicians, we’re doing the same for pharmacists with AIVAe.
AIVAe — Built for the Real World of Pharmacy
AIVAe is already:
- Supporting NHS and PGD services
- Generating consultation records and clinical notes
- Guiding pharmacists through remote care and patient triage
But this is just version one.
We’ve designed AIVAe to be scalable, safe, and smart, with deep awareness of:
- GPhC standards
- NHS delivery frameworks
- The realities of high-pressure, low-margin pharmacy practice
Where We’re Going (Without Revealing Too Much)
While we can’t share everything yet, here’s a glimpse of what’s ahead:
- Intelligent documentation systems
- PMR and third-party integrations
- Workflow-embedded AI support agents
- Tools that reduce clinical risk and increase patient access
Our goal isn’t just to build a product. It’s to build infrastructure – digital foundations that elevate pharmacy the way DocsGPT is doing for medicine.
We’re not chasing valuations.
We’re chasing impact.
And if we succeed, the rest will follow.
The next billion-dollar healthcare AI might not come from a hospital. It might come from a pharmacy.
And it might already be here.